Spontaneous Coronary Artery Dissection National Swiss Registry

Recruiting Observational Study
Spontaneous Coronary Artery Dissection
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Dr. Sophie Degrauwe · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Spontaneous coronary artery dissection (SCAD), is an underdiagnosed pathology, affecting predominantly young women without traditional cardiovascular risk factors and is associated with major adverse outcomes including myocardial infarction, cardiac arrest, or death. Timely diagnosis of SCAD as well as clinical follow-up are of the essence in this pathology associated with major cardiac adverse o…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Subject is ≥18 years of age. * Patient presenting newly diagnosed SCAD or diagnosed with SCAD within the last 5 years. * Subject must be willing to sign a Patient Informed Consent (PIC). Exclusion Criteria: * Patient unwilling or unable to provide informed consent. * Patient…
Contacts

Sophie Degrauwe, Dr

+41795530294

sophie.degrauwe@hcuge.ch

CONTACT

Veronique Menoni, PhD

+41795530917

Veronique.Menoni@hcuge.ch

CONTACT